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Introduction: The objective of this study was to evaluate the
clinical characteristics and long-term outcome of multiple pure
ground-glass opacity (GGO) lesions detected in patients undergoing
pulmonary resection for bronchioloalveolar carcinoma (BAC).
Methods: Between January 2000 and December 2007, 73 patients
underwent pulmonary resection for BAC. Of those, 23 patients had
multiple pure GGOs on their preoperative computed tomography
(CT) scans. Eighty-nine GGO lesions were detected with a median
number of 3 (range, 2–11) per patient. Resection included wedge
resection in 12 patients, lobectomy in 7, lobectomy with wedge
resection in 3, and bilobectomy in 1. Five patients had all GGOs
lesions resected (group I), whereas 18 had some of the GGO lesions
resected and the remaining lesions followed by serial CT scans
(group II). Median follow-up was 40.3 months.
Results: No late death occurred during the follow-up period. In
group I, four patients had no recurrences and one patient developed
a new lesion that was resected and found to be adenocarcinoma. In
group II, GGO lesions either did not change in size (n  15) or
disappeared (n 3) in all patients. No GGO lesions increased in size
or developed a solid component during the follow-up period.
Conclusions: When multiple pure GGO lesions in patients with
BAC remained without surgical resection, there was no change in
their size or features during follow-up. When it is not feasible to
resect all GGO lesions in patients with multifocal BAC, close
follow-up using CT scans represents an alternative to surgical
resection.
Keywords: Ground-glass opacity, Bronchioloalveolar carcinoma,
Follow-up, Surgical resection.
(J Thorac Oncol. 2010;5: 206–210)
With recent advances in diagnostic imaging modalities,pure ground-glass opacity (GGO) lesions have been
increasingly detected on high-resolution computed tomogra-
phy (HRCT) scans.1–4 The correlation between the radiologic
findings of GGO lesions and their pathologic diagnosis has
been extensively studied.5–12 As GGO is a nonspecific find-
ing, it can be caused by various diseases such as inflamma-
tion, fibrosis, or neoplasm.5 In particular, with respect to pure
GGO, the possibility of nonmucinous bronchioloalveolar car-
cinoma (BAC) cannot be excluded. Indeed, BAC usually
appears as multiple pure GGO lesions. Previous genetic
research on BAC using a novel strategy for clonality deter-
mination indicates that these tumors are mostly multifocal,
independent cancers.13 Accordingly, in patients with multiple
pure GGO lesions on HRCT scans, when one of the lesions is
pathologically confirmed as BAC, the remaining lesions may
have the same pathology (i.e., multifocal BAC).
When a GGO lesion is located deep in the hilum or
multiple lesions are scattered in different lobes in patients
with multifocal BAC, it can be difficult to resect them all.
Yet, it has also not been determined whether these lesions
should be resected or followed by serial computed tomogra-
phy (CT) scans. Few reports have demonstrated the fate of
pure GGO lesions in cases where some are not resected and
then followed by CT scans. The objectives of this study were
to (1) evaluate the clinical characteristics and long-term
outcome of multiple pure GGO lesions detected in patients
undergoing pulmonary resection for BAC and (2) report the
fate and follow-up outcome of unresected, residual GGO
lesions.
PATIENTS AND METHODS
Between January 2000 and December 2007, 2361 pa-
tients underwent pulmonary resection for non-small cell lung
cancer at our institution. Pathologic examinations revealed
that among these, 73 patients had BAC according to the
recently revised World Health Organization classification of
lung tumors.14 Of these, 23 patients had multiple pure GGO
lesions on preoperative CT scans and were included in the
study population. Patients who had single GGO lesion were
excluded. Patients who had GGO lesions with a solid com-
ponent (“mixed GGO”) were excluded. Patients who had
adenocarcinoma with BAC features were also excluded.
Medical records were retrospectively reviewed to investigate
the clinical characteristics, GGO features, histopathologic
results, and follow-up outcomes. This study was reviewed
and approved by the Institutional Review Board of Samsung
Medical Center.
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In patients with multiple pure GGO lesions, we tried to
resect pure GGO lesions larger than 10 mm regardless of the
location. For pure GGO lesions smaller than 10 mm, if the
extent of resection was expected to be greater than lobectomy
due to the central location or if there were multiple lesions
scattered throughout multiple lobes, we decided not to resect
such lesions and instead closely follow them using serial CT
scans. No patients underwent percutaneous fine needle aspi-
ration or transbronchial biopsy via bronchoscopy.
All patients were regularly evaluated by CT scans every
3 months for the first 2 years after surgery, and then every 6
months thereafter regardless of whether or not all GGO
lesions were resected. Descriptive statistics were used to
summarize patient characteristics and outcomes. The nor-
mally distributed, continuous data were expressed as mean 
SD. Categorical data were expressed as counts and propor-
tions. Significance was defined as a p value less than 0.05.
RESULTS
Clinical Findings
Patient characteristics and GGO features are summa-
rized in Table 1. There were 11 men (48%) and 12 women
(52%), with a mean age of 57.2  9.3 years (range, 38–78
years). Fifteen patients (65%) had no history of smoking. No
patients had a history of malignancy except for one who had
a colon cancer. A total of 89 GGO lesions were detected in 23
patients, and the median number of GGO lesions per patient
was 3 (range, 2–11). The median size of GGO lesions was 5
mm (range, 3–40). The mean diameter of the resected GGO
lesions was 9 mm, whereas the mean diameter of those that
were followed with imaging studies was 5 mm. GGO lesions
were detected bilaterally in 13 patients (57%) and unilaterally
in 10 (43%). Typical images of CT scans are shown in Figure 1.
Operative Procedures
Operative procedures are listed in Table 2. Preoperative
percutaneous CT-guided marking using a hook wire was
performed in 16 patients (70%). Procedures were done using
video-assisted thoracic surgery in 16 patients (70%). Wedge
resection was performed in 12 patients (52%), lobectomy in
7 (30%), lobectomy with wedge resection in 3 (13%) and
bilobectomy in 1 (4%). Of the 11 patients who had a lobec-
tomy or bilobectomy, 8 underwent conversion from wedge
resection to lobectomy because the possibility of adenocar-
cinoma could not be ruled out based on the intraoperative
frozen section alone. Two patients underwent lobectomy for
a deeply-located lesion and one for multiple lesions in a lobe.
In all patients who underwent lobectomy or bilobectomy,
systematic mediastinal lymph node dissection was done. Five
patients (22%) had all GGO lesions resected, whereas 18
patients (78%) had some GGO lesions resected and the
remaining lesions followed by serial CT scans.
Early Outcomes
No early mortality or morbidity occurred during the
postoperative period. The mean duration of hospital stay was
5.3  2.8 days (range, 2–14 days). Thirty-nine GGO lesions
were resected, and the pathologic diagnoses included nonmu-
cinous BAC in 26 lesions, atypical adenomatous hyperplasia
in 10, anthracofibrosis in 2, and mucinous BAC in 1. All the
11 patients who underwent a mediastinal lymph node dissec-
tion had N0 disease.
Late Outcomes
The median follow-up duration was 40.3 months
(range, 22–110 months). No late death occurred during the
follow-up period, and no patients developed a local recur-
rence or distant metastasis. Of the five patients who had all
GGO lesions resected, four (80%) had no recurrences,
whereas one (20%) developed a new lesion 49 months after
the initial operation. The patient, who had undergone a
bilobectomy for multifocal BAC, received a wedge resection
for the newly developed lesion, which turned out to be
adenocarcinoma. In the 18 patients who had some GGO
lesions resected and the remaining lesions followed by CT
scans, the residual lesions either did not change in size (n 
15, 83%) or disappeared (n  3, 17%) in all patients. No
GGO lesions increased in size or developed a solid compo-
nent during the follow-up period. Patient demographics and
follow-up outcomes are presented in Table 3.
DISCUSSION
GGO is a radiographic finding defined as hazy, in-
creased attenuation of the lung with preservation of bronchial
and vascular margins.5 GGO features arise from a replacing
growth pattern along the alveolar wall.5 Because the pathol-
ogy of GGO may be a neoplasm such as BAC or early-stage
adenocarcinoma, many authors have investigated the corre-
lation of radiologic findings with pathologic diagnosis.5–12
When GGO lesions are substantially large (e.g., 10 mm) or
TABLE 1. Clinical Characteristics and GGO Features
Characteristics
No. of patients (n) 23
Age at operation (yr, mean  SD) 57.2  9.3 (38–78)
Male:female 11:12
History of smoking (n)
Nonsmoker 15
Current smoker 7
Exsmoker 1
History of previous malignancy (n)
No 22
Yes 1a
Total no. of GGO lesions (n) 89
No. of GGO lesions per patient, n, median (range) 3 (2–11)
2 7
3 6
4 6
5 4
Size of GGO lesions, mm, median (range) 5 (3–40)
Location (n)
Bilateral 13
Unilateral 10
a Had a history of colon cancer.
GGO  ground-glass opacity.
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have a solid component, the possibility of adenocarcinoma
cannot be ruled out and they need to be surgically resected to
confirm the pathology.6 Conversely, pure GGO lesions,
which have no solid component, suggest nonmucinous BAC
or its precursors rather than adenocarcinoma. According to
the World Health Organization classification of lung adeno-
carcinoma, the prerequisite for the diagnosis of BAC is that
the lesions demonstrate pure lepidic growth without invasion
of stroma, blood vessels, or pleura.13 Therefore, patients with
“noninvasive” BAC usually have better outcomes than those
with “invasive” adenocarcinoma. Noguchi et al.14 found out
that small peripheral lung adenocarcinomas with a pure BAC
pattern and no invasion had a 100% 5-year survival, whereas
patients with mixed BAC and invasive components had a
survival of 75%.
BAC commonly appears as multiple pure GGO lesions.
Using a novel strategy for clonality determination to examine
BAC genetics, Barsky et al.15 found that these tumors were
mostly multifocal, independent cancers. This finding implies
that multiple pure GGO lesions may be multifocal BAC if
one lesion is pathologically confirmed as BAC. As long as it
is feasible to remove all lesions, the treatment strategy of our
institution for multifocal BAC is complete surgical resection.
Because of the possibility of invasive neoplasm, pathologic
confirmation is needed, particularly for lesions greater than
10 mm or with a solid component. Nevertheless, when one of
the lesions is located deep in the hilum or multiple lesions are
scattered in different lobes, it can be difficult to resect them
all. Patients with marginal cardiopulmonary reserve may be
unable to tolerate multiple or bilateral pulmonary resections.
For those patients in whom complete surgical resection was
not feasible, we decided to not resect some of the lesions and
followed them using serial CT scans. We found that the
remaining GGO lesions did not change in size or even
disappeared, and no lesions increased in size or developed a
solid component during the follow-up period. This outcome
suggests that the remaining lesions might be noninvasive
tumors such as BAC and that they have a very indolent
natural course.
Few reports have demonstrated the fate of multiple pure
GGO lesions in cases where some are not resected and then
followed with serial CT scans. Kodama et al.7 investigated
the natural history of pure GGO, focusing on single pure
FIGURE 1. Typical computed tomography scan images of
multiple ground-glass opacity (GGO) lesions in 50-year-old
asymptomatic woman. A, 8-mm round GGO nodule (arrow)
in the left upper lobe. B, 9-mm oval GGO nodule (arrow)
deep in the right upper lobe. C, 7-mm round GGO nodule
(arrow) with slightly lobulated margin in the right lower
lobe.
TABLE 2. Operative Procedures
Surgical procedures
Wedge resection 12
Lobectomy 10
Simple lobectomy 7
Lobectomy plus ipsilateral wedge resection 2
Lobectomy plus contralateral wedge resection 1
Bilobectomy 1
Rationale for lobectomy
Possibility of invasive ADC on frozen section biopsy 8
Deep in parenchyma 2
Multifocal lesions in a lobe 1
ADC  adenocarcinoma.
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GGO lesions, and suggested that some pure GGO lesions
never progress to clinical disease. We found similar results in
our study of multiple pure GGO lesions, in which we saw no
recurrences or cancer-related deaths during the follow-up
period, even though some lesions were not resected. Patients
with pure GGO lesions seem to have favorable outcomes,
even if they have multiple lesions.
Our favorable outcomes might be due to the relatively
short duration of follow-up. Aoki et al.16 demonstrated that
BAC-pattern tumors (Noguchi type A or B) had longer tumor
doubling times of more than 1 year, with a mean of 880 days,
compared with 252 days of non–BAC-pattern tumors (Nogu-
chi types D, E, and F). Accordingly, persistent pure GGO
lesions should be followed for a minimum of more than 1
year to conclude whether they are invasive or not. In fact,
there are several reports on the malignancy potential of
persistent GGO lesions that show no change in their size
during follow-up.17,18 Moreover, because the mean diameter
of GGO lesions that we decided to not resect was only 5 mm,
even doubling in “three-dimensional” volume might not have
been detected using “two-dimensional” CT scans during the
relatively short duration of follow-up. Nevertheless, it cannot
be denied that pure GGO lesions might be less invasive,
indolent BAC regardless of whether patients have single or
multiple lesions. Therefore, when it is not easy to resect all
GGO lesions based on the location and multiplicity of lesions
or the functional status of the patient, close follow-up using
serial CT scans represents another option.
Nevertheless, the question remains of which lesions
could be initially followed without surgical resection. First of
all, mixed GGO lesions with a solid component should be
resected regardless of size, because solid components are
associated with areas of collapsed alveoli or fibroblastic
proliferation, which signifies more invasive lesions than pure
GGO lesions without a solid component. Many authors have
reported that the solid components in advanced stage lesions
are significantly larger than those in lesions at earlier sta-
ges.19,20 Second, GGO lesions larger than 10 mm should also
be resected. Nakata et al.6 noted that all lesions larger than 10
mm were carcinoma, without exception. In our series, we
only decided not to perform surgical resection on lesions
smaller than 10 mm. Last, centrally located GGO lesions can
be followed to avoid multiple lobectomies or extensive bilat-
eral pulmonary resections unless the lesions are larger than 10
mm or have a solid component. If the lesions show any
change in size or nature on CT scans during follow-up,
surgical resection should be considered for those lesions in
selected patients.
There are no established guidelines regarding the opti-
mal extent of resection for multifocal BAC. Limited resection
is inevitable for patients with multifocal BAC because of the
number of lesions. Nakata et al.21 reported successful results
TABLE 3. Patient Demographics and Follow-up Outcomes
Patient No. Groupa
Age at
Operation (yr) Sex
No. of
Lesions Location
Follow-up
Duration (mo)
Fate of
Residual GGO
New
Lesion
1 II 54 female 2 RML, RLL 110 Disappeared No
2 I 66 male 2 RML, RLL 68 NA Yes
3 II 69 female 7 RUL, LUL, LLL 55 No change No
4 II 78 female 5 RUL, RML, RLL, LUL 48 No change No
5 II 55 male 3 RML, LUL 46 No change No
6 II 57 female 2 RML, LUL 45 No change No
7 I 43 male 2 RLL, LLL 44 NA No
8 II 50 female 10 RUL, RLL, LUL 42 No change No
9 II 59 female 4 RUL, LUL, LLL 42 Disappeared No
10 II 46 female 3 RUL, LUL, LLL 41 No change No
11 II 58 female 2 LUL, LLL 41 No change No
12 II 58 male 4 RLL, LUL, LLL 40 No change No
13 II 62 female 3 RUL, RLL, LUL 40 Disappeared No
14 II 56 male 4 RUL, RLL 37 No change No
15 II 62 female 3 RLL, LLL 35 No change No
16 II 37 male 2 RUL, LLL 35 No change No
17 II 49 female 3 LUL, LLL 34 No change No
18 II 49 male 4 RUL, LUL 34 No change No
19 II 68 male 3 RUL, RLL, LUL 31 No change No
20 I 54 female 4 RUL, RLL 27 NA No
21 I 67 male 4 RUL, RML 26 NA No
22 I 59 male 2 RUL 24 NA No
23 II 50 male 11 RUL, LUL, LLL 23 No change No
a Patients had all GGO lesions resection in group I, whereas patients had some of the GGO lesions resection in group II.
GGO  ground-glass opacity; RUL  right upper lobe; RML  right middle lobe; RLL  right lower lobe; LUL  left upper lobe; LLL  left lower
lobe; NA  not applicable.
Journal of Thoracic Oncology • Volume 5, Number 2, February 2010 Multiple Pure Ground-Glass Opacity Lesions
Copyright © 2010 by the International Association for the Study of Lung Cancer 209
using thoracoscopic wedge resection for pure GGO lesions
selected on HRCT images. They indicated that the area of
GGO on HRCT images could be a useful criterion for
selecting surgical procedures, and that wedge resection could
be valid for pure GGO lesions. Mun et al.,22 in their retro-
spective review of 27 patients with multifocal BAC, demon-
strated that video-assisted thoracic surgery pulmonary resec-
tion was feasible and yielded satisfactory outcomes. They
tried to resect all lesions in every case by wedge resection or
lobectomy. In our study, although some patients received a
lobectomy or even bilobectomy due to the location or
number of the lesions, most patients underwent multiple
wedge resections for multifocal lesions. Considering that
BAC is defined as a noninvasive neoplasm, limited resec-
tion such as wedge resection could be sufficient for each
pure GGO lesion.
Our study has several limitations. First, as mentioned
above, the follow-up duration was rather short. Further ob-
servation for a longer period might have revealed changes in
the size or nature of the remaining GGO lesions. Second, our
data were retrospectively collected in a small series. For
results that are conclusive and persuasive, prospective data
acquisition from a large cohort is needed. Third, in cases with
multiple GGO lesions where only one lesion was pathologi-
cally confirmed, there is no guarantee that the pathologically
confirmed lesion represented the remaining lesions. Although
we excluded GGO lesions with a solid component so that all
of the lesions had a similar morphology, we cannot definitely
conclude that the lesions had the same histopathological
diagnosis.
In summary, we retrospectively reviewed the clinical
characteristics and long-term outcome of multiple pure GGO
lesions detected in patients undergoing pulmonary resection
for BAC and evaluated the fate of residual GGO lesions
subjected to close observation. Multiple pure GGO lesions in
patients with BAC that were not resected did not change in
size or features during the follow-up period. When it is not
feasible to resect all GGO lesions in patients with multifocal
BAC, close follow-up by CT scans represents another option.
When such lesions show any significant change in size or
nature at follow-up CT scans, surgical resection should be
considered in selected cases. Close observation for a longer
duration is needed to strengthen our suggested therapeutic
strategy.
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